Global Health & Medicine -> Current Issue

Review
Drug development targeting SARS-CoV-2 main protease
Global Health & Medicine. 2022; 4(6):296-300.
Original Article
Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer
Global Health & Medicine. 2022; 4(6):301-308.
Outcomes following cholecystectomy in human immunodeficiency virus-positive patients treated with antiretroviral therapy: A retrospective cohort study
Global Health & Medicine. 2022; 4(6):309-314.
Brief Report
Short- and long-term efficacy of bronchial artery embolization using a gelatin sponge for the treatment of cryptogenic hemoptysis
Global Health & Medicine. 2022; 4(6):315-321.
Correspondence
Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant
Global Health & Medicine. 2022; 4(6):322-326.
Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from 2021, and future perspectives in Japan
Global Health & Medicine. 2022; 4(6):327-331.
Infection control of COVID-19 in operating theaters in a designated hospital for specified infectious diseases in Japan
Global Health & Medicine. 2022; 4(6):332-335.
Perspective
Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19
Global Health & Medicine. 2022; 4(6):336-340.
Challenges and the potential of promoting remote medical interpreting during COVID-19
Global Health & Medicine. 2022; 4(6):341-346.
Letter
Gastrointestinal endoscopy trends in a designated hospital for specified infectious diseases in Japan during the dawn of the "living with COVID-19" era
Global Health & Medicine. 2022; 4(6):347-349.